New-onset postpartum preeclampsia: epigenetic mechanism and prediction. (12th December 2022)
- Record Type:
- Journal Article
- Title:
- New-onset postpartum preeclampsia: epigenetic mechanism and prediction. (12th December 2022)
- Main Title:
- New-onset postpartum preeclampsia: epigenetic mechanism and prediction
- Authors:
- Kim, Sun Kwon
Vishweswaraiah, Sangeetha
Macknis, Jacqueline
Yilmaz, Ali
Lalwani, Ashna
Mishra, Nitish K.
Guda, Chittibabu
Ogunyemi, Dotun
Radhakrishna, Uppala
Bahado-Singh, Ray O. - Abstract:
- Abstract: Objective: Placental cytosine (CpG) methylation was measured to predict new-onset postpartum preeclampsia (NOPP) and interrogate its molecular pathogenesis. Methods: NOPP was defined as patients with a new diagnosis of postpartum preeclampsia developing ≥48 h to ≤6 weeks after delivery with no prior hypertensive disorders. Placental tissue was obtained from 12 NOPP cases and 12 normotensive controls. Genome-wide individual cytosine (CpG) methylation level was measured with the Infinium MethylationEPIC BeadChip array. Significant differential methylation (NOPP vs. controls) for individual CpG loci was defined as false discovery rate (FDR) p value <.05. Gene functional enrichment using Qiagen's ingenuity pathway analysis (IPA) was performed to help elucidate the molecular pathogenesis of NOPP. A logistic regression model for NOPP prediction based on the methylation level in a combination of CpG loci was generated. The area under the receiver operating characteristic curves (AUC [95% CI]) sensitivity, and specificity for NOPP prediction based on the CpG methylation level was calculated for each locus. Results: There were 537 (in 540 separate genes) significantly (FDR p <.05 with a ≥ 2.0-fold methylation difference) differentially methylated CpG loci between the groups. A total of 143 individual CpG markers had excellent individual predictive accuracy for NOPP prediction (AUC ≥0.80), of which 14 markers had outstanding accuracy (AUC ≥0.90). A logistic regression modelAbstract: Objective: Placental cytosine (CpG) methylation was measured to predict new-onset postpartum preeclampsia (NOPP) and interrogate its molecular pathogenesis. Methods: NOPP was defined as patients with a new diagnosis of postpartum preeclampsia developing ≥48 h to ≤6 weeks after delivery with no prior hypertensive disorders. Placental tissue was obtained from 12 NOPP cases and 12 normotensive controls. Genome-wide individual cytosine (CpG) methylation level was measured with the Infinium MethylationEPIC BeadChip array. Significant differential methylation (NOPP vs. controls) for individual CpG loci was defined as false discovery rate (FDR) p value <.05. Gene functional enrichment using Qiagen's ingenuity pathway analysis (IPA) was performed to help elucidate the molecular pathogenesis of NOPP. A logistic regression model for NOPP prediction based on the methylation level in a combination of CpG loci was generated. The area under the receiver operating characteristic curves (AUC [95% CI]) sensitivity, and specificity for NOPP prediction based on the CpG methylation level was calculated for each locus. Results: There were 537 (in 540 separate genes) significantly (FDR p <.05 with a ≥ 2.0-fold methylation difference) differentially methylated CpG loci between the groups. A total of 143 individual CpG markers had excellent individual predictive accuracy for NOPP prediction (AUC ≥0.80), of which 14 markers had outstanding accuracy (AUC ≥0.90). A logistic regression model based on five CpG markers yielded an AUC (95% CI)=0.99 (0.95–0.99) with sensitivity 95% and specificity 93% for NOPP prediction. IPA revealed dysregulation of critical pathways (e.g., angiogenesis, chronic inflammation, and epithelial–mesenchymal transition) known to be linked to classic preeclampsia, in addition to other previously undescribed genes/pathways. Conclusions: There was significant placental epigenetic dysregulation in NOPP. NOPP shared both common and unique molecular pathways with classic preeclampsia. Finally, we have identified novel potential biomarkers for the early post-partum prediction of NOPP. … (more)
- Is Part Of:
- Journal of maternal-fetal & neonatal medicine. Volume 35:Number 25(2022)
- Journal:
- Journal of maternal-fetal & neonatal medicine
- Issue:
- Volume 35:Number 25(2022)
- Issue Display:
- Volume 35, Issue 25 (2022)
- Year:
- 2022
- Volume:
- 35
- Issue:
- 25
- Issue Sort Value:
- 2022-0035-0025-0000
- Page Start:
- 7179
- Page End:
- 7187
- Publication Date:
- 2022-12-12
- Subjects:
- Postpartum preeclampsia -- placenta -- epigenetics -- biomarkers -- pathway analysis
Obstetrics -- Periodicals
Perinatology -- Periodicals
Infants (Newborn) -- Diseases -- Periodicals
Neonatology -- Periodicals
618.2 - Journal URLs:
- http://informahealthcare.com/loi/jmf ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/14767058.2021.1946504 ↗
- Languages:
- English
- ISSNs:
- 1476-7058
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5012.332000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 24418.xml